Skip to main content
. 2022 Jul 20;2022(7):CD013690. doi: 10.1002/14651858.CD013690.pub2

Peng 2017.

Study name Choice of anaesthesia for endovascular treatment of acute ischemic stroke: protocol for a randomised controlled (CANVAS) trial
Methods Setting: single‐centre, China
Design: RCT, 2 arms, parallel assignment, open‐label single‐blind
Start date: 5 February 2016 (reported in protocol)
Completion date: December 2022 (reported in protocol)
Participants 640 men and women aged ≥ 18 years
Inclusion criteria
  • Men and women aged 18 years with AIS who are suitable for emergency EVT, fulfilling all of the following criteria:

    • 6 hours after the onset of stroke

    • Functionally independent prior to stroke with mRS score 2

    • Symptomatic intracranial occlusion, based on single phase, multiphase or dynamic CTA/MRA or DSA, at ≥ 1 of the following locations: ICA, M1, and M2 segments equivalent affecting 4 50% of MCA territory

    • Neuroradiologists and anaesthesiologists agree to proceed with EVT with GA or LA


Exclusion criteria
  • Moribund on admission

  • People who require tracheal intubation for airway protection or were intubated on admission

  • GCS score 8

  • ASPECTS 6

  • Current NIHSS score > 30 or < 8

  • Severe agitation or seizures

  • Loss of airway protective reflexes or vomiting, or both

  • Additional intracerebral haemorrhage on brain imaging

  • Posterior circulation infarction

  • Known allergy to anaesthetics or analgesics

Interventions Experimental: GA
Comparator: LA
Outcomes Primary outcomes
  • Global disability measured by mRS at 90 days after randomisation. Favourable neurological outcome defined as mRS ≤ 2


Secondary outcomes
  • Change in NIHSS at 24 hours, 7 days (or at discharge), 30 days, and 3 months after randomisation

  • mTICI score before and after EVT

  • Intraprocedural systolic blood pressure, diastolic blood pressure, heart rate, and end‐tidal carbon dioxide at 10‐minute intervals

  • All‐cause mortality up to 3 months after randomisation

  • Incidence of complications up to 3 months after randomisation

  • Length of stay in hospital or ICU after randomisation

  • MOCA and MMSE assessed at 24 hours, 7 days (or at discharge), 30 days, and 3 months after randomisation

  • Rate of delirium as measured by CAM after randomisation

Starting date 5 February 2016
Contact information Ruquan Han
Beijing Tiantan Hospital, China
8610‐67096660; ruquan.han@gmail.com
Notes NCT02677415

AIS: acute ischaemic stroke; ASPECTS: Alberta Stroke Program Early Computed Tomography Score; CAM: Confusion Assessment Method; CSA: conscious sedation anaesthesia; CT: computed tomography; CTA: computed tomography angiography; DSA: digital subtraction angiography; EVT: endovascular treatment; GA: general anaesthesia; GCS: Glasgow Coma Score; ICA: internal carotid artery; ICU: intensive care unit; LA: local anaesthesia; LVO: large vessel occlusion; MCA: middle cerebral artery; MMSE: Mini‐Mental State Examination; MOCA: Montreal Cognitive Assessment; MRA: magnetic resonance angiography; MRI: magnetic resonance imaging; mRS: modified Rankin Scale; mTICI: modified treatment in cerebral ischaemia; NIHSS: National Institutes of Health Stroke Scale; pc‐ASPECTS: post‐circulation Alberta Stroke Program Early Computed Tomography Score; RCT: randomised controlled trial; tPA: tissue plasminogen activator.